moa of semaglutide Mechanism Action: How GLP-1 Works Semaglutide Vs Tirzepatide For Weight

Innovative Weight Loss Programs We understand that weight loss is a deeply personal and often challenging journey

Sections were incubated with Alexa Fluor goat anti-rabbit IgG and Alexa Fluor goat anti-mouse IgG (1:500, Life Technologies, Grand Island, NY) at RT for 1 h and counterstained with DAPI

For instance, while topical agents may suffice for localized mild disease, systemic therapies are often warranted for extensive or refractory cases (Rendon & Schakel 2019)

Yes, repeated injections into the same small area can cause lipohypertrophyabnormal fat thickening that reduces medication absorption and increases discomfort

Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved